Literature DB >> 11807171

Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

Zhong-Yin Zhang1.   

Abstract

Protein tyrosine phosphatases (PTPs) are signaling enzymes that control a diverse array of cellular processes. Malfunction of PTP activity is associated with a number of human disorders. Recent genetic and biochemical studies indicate that PTPs represent a novel platform for drug discovery. Detailed knowledge of PTP substrate specificity and the wealth of structural data on PTPs provide a solid foundation for rational PTP inhibitor design. This review summarizes a correlation of PTP structure and function from mutagenesis experiments. The molecular basis for PTP1B and MKP3 substrate recognition is discussed. A powerful strategy is presented for creating specific and high-affinity bidentate PTP inhibitors that simultaneously bind both the active site and a unique adjacent site. Finally, recent advances in the development of potent and selective inhibitors for PTP1B and Cdc25 are described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807171     DOI: 10.1146/annurev.pharmtox.42.083001.144616

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  121 in total

1.  Design and synthesis of nonpeptidic, small molecule inhibitors for the Mycobacterium tuberculosis protein tyrosine phosphatase PtpB.

Authors:  Katherine A Rawls; Christoph Grundner; Jonathan A Ellman
Journal:  Org Biomol Chem       Date:  2010-07-19       Impact factor: 3.876

2.  Conformational basis for substrate recruitment in protein tyrosine phosphatase 10D.

Authors:  Lalima L Madan; B Gopal
Journal:  Biochemistry       Date:  2011-10-27       Impact factor: 3.162

Review 3.  Kinetic isotope effects in the characterization of catalysis by protein tyrosine phosphatases.

Authors:  Alvan C Hengge
Journal:  Biochim Biophys Acta       Date:  2015-04-01

4.  Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2).

Authors:  Xian Zhang; Yantao He; Sijiu Liu; Zhihong Yu; Zhong-Xing Jiang; Zhenyun Yang; Yuanshu Dong; Sarah C Nabinger; Li Wu; Andrea M Gunawan; Lina Wang; Rebecca J Chan; Zhong-Yin Zhang
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

5.  Discovery of protein phosphatase 2C inhibitors by virtual screening.

Authors:  Jessica P Rogers; Albert E Beuscher; Marc Flajolet; Thomas McAvoy; Angus C Nairn; Arthur J Olson; Paul Greengard
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

6.  In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation.

Authors:  Shuangding Wu; Massimo Bottini; Robert C Rickert; Tomas Mustelin; Lutz Tautz
Journal:  ChemMedChem       Date:  2009-03       Impact factor: 3.466

7.  S-nitrosylated SHP-2 contributes to NMDA receptor-mediated excitotoxicity in acute ischemic stroke.

Authors:  Zhong-Qing Shi; Carmen R Sunico; Scott R McKercher; Jiankun Cui; Gen-Sheng Feng; Tomohiro Nakamura; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  Activity-Based Profiling Reveals a Regulatory Link between Oxidative Stress and Protein Arginine Phosphorylation.

Authors:  Jakob Fuhrmann; Venkataraman Subramanian; Douglas J Kojetin; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2016-08-11       Impact factor: 8.116

9.  Overproduction, purification and structure determination of human dual-specificity phosphatase 14.

Authors:  George T Lountos; Joseph E Tropea; Scott Cherry; David S Waugh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16

10.  Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.

Authors:  Mark R Karver; Divya Krishnamurthy; Nunzio Bottini; Amy M Barrios
Journal:  J Inorg Biochem       Date:  2009-12-28       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.